Consistent with this concept, the TLR4 inhibitor TAK-242 (Resatorvid) has been examined in in vitro and in vivo animal models of RA, where Resatorvid improved inflammatory symptoms (e.g., in joint tissues of arthritic rats) [24]. This evidence concerns the gene TLR4 and rheumatoid arthritis.